MSP Recovery, Inc. Announces Conclusion of SEC Investigation: No Intention to Recommend Enforcement Action Against the Company, its CEO, John H. Ruiz, or its Officers 
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
Fireside chat scheduled for Tuesday, December 2, 2025 at 12:30 PM ETNEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- TG...
Kane Biotech Announces Third Quarter 2025 Financial Results
WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced...
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug Agency (CDA-AMC) for inflammatory bowel diseases,...
Shriners Hospitals for Children Canada and Children’s Hospital at LHSC launch landmark research program to advance care in rare childhood bone disorders
One-year anniversary of affiliation marked by national expansion in research and care for kids with complex conditionsMONTREAL and LONDON, Ontario,...
Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025
Daix (France), New York City (New York, United States), November 28, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”),...
Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer
Oslo, Norway, 28 November 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T Cell Receptor-based Natural Killer (TCR-NK)...
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the...
Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the...
HealthTab™ to Power NHS Pilot
Bringing Cholesterol-Lowering Injections to U.K. Community PharmaciesVANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR)...
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET /...
Dipharma publishes a peer-reviewed study in Organic Process Research & Development: a novel approach to detect and characterize nitrosamine formation in APIs
The pioneer method combines the nitrosation assay procedure (NAP) with 15N-enriched nitrosating reagents and 15N NMR spectroscopy for a safer...
GENFIT Announces Appointment of new Chief Medical Officer
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to...
Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Women’s Healthcare Innovation
New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism...
Report finds adoption of barcoding system in Canadian healthcare can save billions annually while supporting patient safety
TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- A new report prepared by Deloitte Canada and commissioned by GS1 Canada finds...
Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade
Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as...
DentScribe.ai Introduces Advanced In-App Diagnostics and Support to Power Enterprise-Grade Reliability
PALO ALTO, Calif., Nov. 28, 2025 /PRNewswire/ -- DentScribe.ai today announced a major supportability update that brings self-service diagnostics, instant...
Yale-Trained Neuroscientist Unveils “Digital Sunshine” Device, Merging Ancient Eastern Wisdom with Modern Brain Science to Revolutionize Sleep
Panbrain Lume Offers a Drug-Free Path to Deeper Sleep and Faster Sleep Onset in Just 8 Minutes, Now Live on...
Keep Your Respiratory Health Strong This Season With VARON Black Friday Offers
NEW YORK, Nov. 27, 2025 /PRNewswire/ -- As the holiday season approaches, respiratory health becomes a top priority for individuals...
Promino Nutritional Sciences Inc. Announces Revocation of Cease Trade Order
Burlington, Ontario--(Newsfile Corp. - November 27, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) (the "Company"...
Thanksgiving Wishes to the DEA’s Anti Cannabis Holdouts – And Gently Suggests They Spend a Moment Thinking About Patients Waiting for Legal Medicine
MMJ Wishes DEA Officials a Happy Thanksgiving - While Reminding Them That Huntington's Chorea Doesn't Take Holidays. WASHINGTON, D.C. /...